Related Experiment Videos
Endplate dysfunction causing respiratory failure in a patient with prior paralytic poliomyelitis
A Truffert1, P H Lalive, J P Janssens
1Clinique de Neurologie, Unité ENMG et des Affections Neuromusculaires, Hôpital Cantonal Universitaire, Geneva, Switzerland. andre.truffert@hcuge.ch
Journal of Neurology, Neurosurgery, and Psychiatry
|February 18, 2003
Summary
Patients with postpolio syndrome experiencing breathing difficulties may have neuromuscular junction dysfunction. Anticholinesterase treatment can improve respiratory function in these cases.
Area of Science:
- Neurology
- Respiratory Medicine
- Clinical Electrophysiology
Background:
- Poliomyelitis survivors can develop late sequelae, including respiratory muscle weakness.
- Progressive dyspnea in postpolio syndrome can necessitate mechanical ventilation.
- Autoimmune myasthenia gravis is a common cause of neuromuscular junction dysfunction.
Observation:
- A 56-year-old male with postpolio syndrome presented with progressive dyspnea requiring intensive care unit admission and mechanical ventilation.
- Repetitive nerve stimulation studies revealed a significant decrement in trapezius muscle response, characteristic of neuromuscular transmission defects.
- The muscle response decrement was notably reversed by edrophonium, an acetylcholinesterase inhibitor.
Findings:
- Anticholinesterase therapy led to considerable and sustained improvement in the patient's ventilatory function.
- The absence of serological markers for autoimmune myasthenia gravis suggested an alternative etiology.
- Endplate dysfunction, potentially linked to postpolio syndrome, was proposed as the underlying mechanism.
Implications:
- Repetitive nerve stimulation is a valuable diagnostic tool for identifying treatable neuromuscular junction dysfunction in postpolio syndrome.
- Anticholinesterase treatment should be considered for postpolio syndrome patients with respiratory compromise and electrophysiological evidence of neuromuscular transmission defects.
- This finding expands therapeutic options for managing respiratory insufficiency in the late stages of poliomyelitis sequelae.